Skip to main content

Table 1 CT findings in the 30 patients of study population

From: The role of 18-FDG PET/CT assessment of functional brain metabolism in cancer patients after chemotherapy

Primary Adenocarcinoma of the spine 1 3.3%
Ovarian cancer 1 3.3%
Breast cancer 9 30.0%
Bronchogenic carcinoma 8 26.6%
Colonic cancer 1 3.3%
Hepatic focal lesions 1 3.3%
Lacrimal gland neoplasm 1 3.3%
Lymphoma 4 13.3%
Palatal melanoma 1 3.3%
Parotid neoplasm 2 6.7%
RCC 1 3.3%